glp-1 antagonists receptor agonists show promise in treating substance use disorders America's Poison Centers - GLP-1

A post-hoc analysis of STEP 1, 2, 3, and 5 found a small but statistically significant reduction in depressive symptoms with semaglutide compared to placebo

[DOI] [PubMed] [Google Scholar] 59.Margulies K.B., Hernandez A.F., Redfield M.M., Givertz M.M., Oliveira G.H., Cole R., Mann D.L., Whellan D.J., Kiernan M.S., Felker G.M., et al

16 Hims & Hers Health, a U.S.-based telemedicine company, has recently announced future plans to provide GLP-1RA drugs as part of its new weight-loss platform, alongside personalized nutrition guidance, digital tracking tools, mental health support, etc

For Dr Ambrish Mithal, chairman of endocrinology and diabetes at Max Healthcare, the study answers a long-standing question about the effects of discontinuing GLP-1 drugs during pregnancy

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

In certain cases, specific medications may be considered